Intensity Therapeutics, Inc. Common stock (INTS NASDAQ) stock market data APIs
$5.2487
-0.06(-1.1%)
as of May 4, 2026
Try our APIs with
free plan!
Intensity Therapeutics, Inc. Common stock Financial Data Overview
Price chart is built with
Anychart
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Prev. Close
5.2487
Open
5.1868
High
5.3328
Low
5.1621
52 wk Range
4.625-43.5
Market Cap
13 185 K
Shares Outstanding
2 541 K
EPS
0
Beta
4.232
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Intensity Therapeutics, Inc. Common stock data using free add-ons & libraries
Get Intensity Therapeutics, Inc. Common stock Fundamental Data
Intensity Therapeutics, Inc. Common stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Intensity Therapeutics, Inc. Common stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.0567
Get Intensity Therapeutics, Inc. Common stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Intensity Therapeutics, Inc. Common stock News
New
Trending tickers: Apple, Amazon, Netflix, Reddit and Intensity Therapeutics
Apple (AAPL) Shares in Apple (AAPL) were higher in pre-market trading following the tech giant's fiscal fourth-quarter results, which exceeded Wall Street's expectations. Apple posted total revenue ...
Stay updated with the stocks that are on the move in today's after-hours session.
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. [postmarket] AFTER HOURS GAINERS TICKER CHANGE COMMENT THAR [https://www.char...
Intensity Therapeutics regains compliance with Nasdaq requirement
Intensity Therapeutics (NASDAQ:INTS [https://seekingalpha.com/symbol/INTS]) said [https://seekingalpha.com/pr/20197325-intensity-therapeutics-inc-regains-compliance-with-nasdaqs-minimum-stockholders-e...
Intensity Therapeutics GAAP EPS of -$0.13
* Intensity Therapeutics press release [https://seekingalpha.com/pr/20194119-intensity-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate] (NASDAQ:INTS [https://seekin...
Get Intensity Therapeutics, Inc. Common stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
